Mesenchymal stem cell-derived exosomes for premature ovarian failure: mechanisms, therapeutic potential, and bioengineering strategies

Premature ovarian failure (POF) is exhibiting a progressively younger onset age. Its etiology involves multiple factors, including genetics, immunity, mitochondrial dysfunction, iatrogenic causes, and environmental influences. This disease can lead to infertility, menstrual irregularities, hot flushes, and urogenital atrophy, severely compromising women’s reproductive health and quality of life. Given the limited available therapeutic options, there is an urgent need to explore novel treatment strategies. Exosomes derived from mesenchymal stem cells (MSC-exos) are a cell-free therapy for the treatment of POF, with low oncogenic risks and immunogenicity. Studies have confirmed that the MSC-exos ameliorate POF through multiple mechanisms, including regulating the proliferation and apoptosis of granulosa cells (GCs), activating follicular development, promoting angiogenesis, resisting oxidative stress, alleviating fibrosis, and inhibiting inflammation. This review systematically summarizes the etiology and pathological characteristics of POF, elaborates the specific mechanisms of the exosomes in POF, and explores exosomes optimization strategies based on preconditioning, surface functionalization, genetic engineering, tissue engineering, and exosome-based drug delivery. Finally, in light of the current state of the field, it critically discusses the limitations of MSC-exos in premature ovarian failure-related research and their application prospects. This narrative review provides valuable insights and novel research directions for the design of innovative therapeutic strategies against POF.

Authors

Institutions

Publication Details

Journal
Stem Cell Research & Therapy
Published
2026-11-17
DOI
https://doi.org/10.1186/s13287-026-05397-4
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Mesenchymal stem cell-derived exosomes for premature ovarian failure: mechanisms, therapeutic potential, and bioengineering strategies

Panqing Wu, Chao Cong, Xiyu Liu
3 links
Stem Cell Research & Therapy
Extracellular vesicles in disease
article

Mesenchymal stem cell-derived exosomes for premature ovarian failure: mechanisms, therapeutic potential, and bioengineering strategies

Panqing Wu, Chao Cong, Xiyu Liu
article en

Abstract

Premature ovarian failure (POF) is exhibiting a progressively younger onset age. Its etiology involves multiple factors, including genetics, immunity, mitochondrial dysfunction, iatrogenic causes, and environmental influences. This disease can lead to infertility, menstrual irregularities, hot flushes, and urogenital atrophy, severely compromising women’s reproductive health and quality of life. Given the limited available therapeutic options, there is an urgent need to explore novel treatment strategies. Exosomes derived from mesenchymal stem cells (MSC-exos) are a cell-free therapy for the treatment of POF, with low oncogenic risks and immunogenicity. Studies have confirmed that the MSC-exos ameliorate POF through multiple mechanisms, including regulating the proliferation and apoptosis of granulosa cells (GCs), activating follicular development, promoting angiogenesis, resisting oxidative stress, alleviating fibrosis, and inhibiting inflammation. This review systematically summarizes the etiology and pathological characteristics of POF, elaborates the specific mechanisms of the exosomes in POF, and explores exosomes optimization strategies based on preconditioning, surface functionalization, genetic engineering, tissue engineering, and exosome-based drug delivery. Finally, in light of the current state of the field, it critically discusses the limitations of MSC-exos in premature ovarian failure-related research and their application prospects. This narrative review provides valuable insights and novel research directions for the design of innovative therapeutic strategies against POF.

Stem Cell Research & Therapy
Shanghai University of Traditional Chinese Medicine (CN), Longhua Hospital Shanghai University of Traditional Chinese Medicine (CN), Wangjing Hospital of China Academy of Chinese Medical Sciences (CN), China Academy of Chinese Medical Sciences (CN)
National Natural Science Foundation of China
Good health and well-being
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon